The case for including more babies and young children in medical research
All medicines and treatments have to go through lengthy safety and efficacy testing, but this is particularly tricky – and often delayed – for one important age group. Elna Schütz explores the complexities of conducting clinical trials involving babies, and why those complexities are worth grappling with.
